contraloid

Small moleculeexperimental

Clinical trial activity

4 trials · 14 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Apr 9, 2018 (NCT03944460)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06182085Phase 2Dec 1, 2023Government of Germany, PRInnovation GmbH, Utrecht University
NCT04711486Phase 1Dec 8, 2020Berlin Institute of Health, Government of Germany, Humboldt University
NCT03955380Phase 1Dec 12, 2018Alzheimer's Association, Forschungszentrum Jülich, Fundación Teófilo Hernando, Spain, Helmholtz Centre for Infection Research, Medical University of Vienna, NeuroScios GmbH, Nuvisan Pharma Services, University of Vienna
NCT03944460Phase 1Apr 9, 2018Forschungszentrum Jülich, Fundación Teófilo Hernando, Spain, Helmholtz Centre for Infection Research, Medical University of Vienna, NeuroScios GmbH, Triskelion, The Netherlands, University of Vienna
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (14)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Forschungszentrum JülichAcademic/Hospital2012018
Fundación Teófilo Hernando, SpainAcademic/Hospital2012018
Government of GermanyGovernment2022020
Helmholtz Centre for Infection ResearchAcademic/Hospital2012018
Medical University of ViennaAcademic/Hospital2012018
NeuroScios GmbHFor profit2012018
University of ViennaAcademic/Hospital2212018
Alzheimer's AssociationAcademic/Hospital1012018
Berlin Institute of HealthAcademic/Hospital1012020
Humboldt UniversityAcademic/Hospital1112020
Nuvisan Pharma ServicesFor profit1012018
PRInnovation GmbHFor profit1112023
Triskelion, The NetherlandsAcademic/Hospital1012018
Utrecht UniversityAcademic/Hospital1012023
14 organizations
Page 1 / 1